ADAPTIMMUNE THERAPEUTICS PLC: accounts_receivable
| Value | {"amount": 12500000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-09-30) |
| Status | current |
| Entity | ADAPTIMMUNE THERAPEUTICS PLC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:40:50.704147+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f05c1cc2-b2e2-4b71-b58d-e3f1e87543c7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-24-015532 · Open the official SEC filing →Retrieved: 2026-08-19T16:40:50.704147+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001621227/accounts-receivable/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f05c1cc2-b2e2-4b71-b58d-e3f1e87543c7
History
- no predecessors — first report